Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Denosumab for Spinal Cord Injury
Recruiting3 awardsPhase 4
West Orange, New Jersey
This trial is testing whether Denosumab can help prevent bone loss in legs due to SCI. The study will last for 12 months, with 6 visits ranging from 1-4.5 hours. The trial is double-blinded, meaning participants will be randomly assigned to Denosumab or placebo injections, not knowing which they are receiving.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.